Key clinical point: As the incidence of metastatic renal cell carcinoma (RCC) continues to rise, knowledge of skeletal-related events and appropriate interventions is essential.
Major finding: About 85% of patients with metastatic RCC experience skeletal-related events and associated complications.
Study details: A literature review of skeletal metastasis in RCC.
Disclosures: The study did not receive specific funding.
Umer M et al. Ann Med Surg. 2018 Jan 21. doi: 10.1016/j.amsu.2018.01.002
Must Reads in Genitourinary Cancer
First-line avelumab/axitinib for RCC benefits wide range of patients, Choueiri TK et al. GUCS 2019, Abstract 544.